Literature DB >> 31003998

With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study.

Nathanael R Fillmore1,2,3, Sarvari V Yellapragada4,5, Chizoba Ifeorah4,5, Ansh Mehta6, Diana Cirstea1,7, Paul S White1,7, Gustavo Rivero4,5, Andrew Zimolzak1,5, Saiju Pyarajan1,2, Nhan Do1,7, Mary Brophy1,7, Nikhil C Munshi1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31003998      PMCID： PMC6566591          DOI： 10.1182/blood.2019000406

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  24 in total

1.  Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients.

Authors:  Hakan Kaya; Benjamin Peressini; Irfan Jawed; Danko Martincic; Ameer L Elaimy; Wayne T Lamoreaux; Robert K Fairbanks; Kevin A Weeks; Christopher M Lee
Journal:  Int J Hematol       Date:  2011-12-09       Impact factor: 2.490

2.  Racial disparities in treatment use for multiple myeloma.

Authors:  Mark A Fiala; Tanya M Wildes
Journal:  Cancer       Date:  2017-01-13       Impact factor: 6.860

3.  Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups.

Authors:  Sikander Ailawadhi; Ibrahim T Aldoss; Dongyun Yang; Pedram Razavi; Wendy Cozen; Taimur Sher; Asher Chanan-Khan
Journal:  Br J Haematol       Date:  2012-04-26       Impact factor: 6.998

4.  Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: a single center study.

Authors:  Vishal Bhatnagar; Yin Wu; Olga G Goloubeva; Kathleen T Ruehle; Todd E Milliron; Carolynn G Harris; Aaron P Rapoport; Saul Yanovich; Edward A Sausville; Maria R Baer; Ashraf Z Badros
Journal:  Cancer       Date:  2014-12-02       Impact factor: 6.860

5.  Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.

Authors:  Bita Fakhri; Mark A Fiala; Sascha A Tuchman; Tanya M Wildes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2018-01-31

6.  Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications.

Authors:  E Dianne Pulte; Lei Nie; Nicole Gormley; Kirsten B Goldberg; Amy McKee; Ann Farrell; Richard Pazdur
Journal:  Blood Adv       Date:  2018-01-23

7.  Recent improvement in survival of patients with multiple myeloma: variation by ethnicity.

Authors:  Dianne Pulte; Maria Theresa Redaniel; Hermann Brenner; Lina Jansen; Mona Jeffreys
Journal:  Leuk Lymphoma       Date:  2013-09-03

8.  Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial.

Authors:  S Vincent Rajkumar; Susanna Jacobus; Natalie S Callander; Rafael Fonseca; David H Vesole; Michael E Williams; Rafat Abonour; David S Siegel; Michael Katz; Philip R Greipp
Journal:  Lancet Oncol       Date:  2009-10-21       Impact factor: 41.316

9.  The impact of race on outcomes of autologous transplantation in patients with multiple myeloma.

Authors:  Pramvir S Verma; Robin S Howard; Brendan M Weiss
Journal:  Am J Hematol       Date:  2008-05       Impact factor: 10.047

10.  Autologous haematopoietic stem cell transplantation in multiple myeloma patients from ethnic minority groups in an equal access healthcare system.

Authors:  Holger W Auner; Jiri Pavlu; Richard Szydlo; Chrissy Giles; Ed Kanfer; Donald Macdonald; David Marin; Dragana Milojkovic; Katayoun Rezvani; John M Goldman; Jane F Apperley; Ola Landgren; Amin Rahemtulla
Journal:  Br J Haematol       Date:  2011-11-03       Impact factor: 6.998
View more
  30 in total

1.  How researchers are addressing the racial imbalance in multiple myeloma.

Authors:  Cassandra Willyard
Journal:  Nature       Date:  2020-11       Impact factor: 49.962

2.  Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis.

Authors:  Sikander Ailawadhi; Kejal Parikh; Safiya Abouzaid; Zhou Zhou; Wenxi Tang; Zoe Clancy; Claudia Cheung; Zheng-Yi Zhou; Jipan Xie
Journal:  Blood Adv       Date:  2019-10-22

3.  Vitamin D deficiency predicts for poor overall survival in white but not African American patients with multiple myeloma.

Authors:  Sarvari V Yellapragada; Nathanael R Fillmore; Anna Frolov; Yang Zhou; Pallavi Dev; Hassan Yameen; Chizoba Ifeorah; Nhan V Do; Mary T Brophy; Nikhil C Munshi
Journal:  Blood Adv       Date:  2020-04-28

4.  Socioeconomic Disparities in Pancreas Cancer Resection and Survival in the Veterans Health Administration.

Authors:  Jonathan Pastrana Del Valle; Nathanael R Fillmore; George Molina; Mark Fairweather; Jiping Wang; Thomas E Clancy; Stanley W Ashley; Richard D Urman; Edward E Whang; Jason S Gold
Journal:  Ann Surg Oncol       Date:  2022-01-10       Impact factor: 5.344

Review 5.  Racial disparities in hematopoietic stem cell transplant: a systematic review of the literature.

Authors:  Ian Landry
Journal:  Stem Cell Investig       Date:  2021-12-14

6.  Don't Compromise Myeloma Care Due to COVID-19 Pandemic!

Authors:  Nikhil C Munshi; Kenneth C Anderson
Journal:  Blood Cancer Discov       Date:  2020-10-13

7.  Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.

Authors:  Pashna N Munshi; David Vesole; Artur Jurczyszyn; Jan Maciej Zaucha; Andrew St Martin; Omar Davila; Vaibhav Agrawal; Sherif M Badawy; Minoo Battiwalla; Saurabh Chhabra; Edward Copelan; Mohamed A Kharfan-Dabaja; Nosha Farhadfar; Siddhartha Ganguly; Shahrukh Hashmi; Maxwell M Krem; Hillard M Lazarus; Ehsan Malek; Kenneth Meehan; Hemant S Murthy; Taiga Nishihori; Rebecca L Olin; Richard F Olsson; Jeffrey Schriber; Sachiko Seo; Gunjan Shah; Melhem Solh; Jason Tay; Shaji Kumar; Muzaffar H Qazilbash; Nina Shah; Parameswaran N Hari; Anita D'Souza
Journal:  Cancer       Date:  2020-09-23       Impact factor: 6.860

8.  Participation of Black Americans in Cancer Clinical Trials: Current Challenges and Proposed Solutions.

Authors:  Muhammad Awidi; Samer Al Hadidi
Journal:  JCO Oncol Pract       Date:  2021-05

9.  Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study.

Authors:  Samer Al Hadidi; Deepa Dongarwar; Hamisu M Salihu; Rammurti T Kamble; Premal Lulla; LaQuisa C Hill; George Carrum; Carlos A Ramos; Helen E Heslop; Saad Z Usmani
Journal:  Leuk Lymphoma       Date:  2021-07-18

Review 10.  Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies.

Authors:  Vanessa Innao; Alessandro Allegra; Lia Ginaldi; Giovanni Pioggia; Massimo De Martinis; Caterina Musolino; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.